The European Society for Paediatric Gastroenterology and Nutrition (ESPGAN) criteria for diagnosing coeliac disease include, after initial diagnosis, prechallenge verification of normal small bowel mucosa and postchallenge mucosal relapse. ' 2 In Finland the clinical picture of coeliac disease has changed to milder forms, resulting in an upward shift of age at diagnosis.3 In fact, over 60% of the diagnoses today are made at school age and during adolescence. The current problem is when to apply gluten challenge in children with late diagnosis. It has also been discussed whether routine gluten challenge should be performed at all, as only a few patients with coeliac disease will not relapse after gluten reintroduction.4 On the other hand puberty could be a milestone in coeliac disease, after which the disease behaves differently. In 
Results
Twenty two patients who were negative for IgA class reticulin antibodies became positive within 0-2-2-0 years (mean 0.6). The titres varied from 1:100 to 1:4000. Fifteen of the 22 adolescents and young adults had noticed no changes in their well being and seven had experienced slight to moderate abdominal symptoms at the time of appearance of reticulin antibodies. One patient had selective IgA deficiency: she had no IgA reticulin antibodies throughout but after 0-9 years of gluten challenge she was found to be positive for IgG class reticulin antibodies (1:200). No symptoms had occurred.
In all 23 patients who were positive for reticulin antibodies a clear mucosal relapse was observed on biopsy. Seventeen patients (74%) showed small, flat intestinal mucosa, two patients showed severe partial villous atrophy, and four moderate partial villous atrophy.
One patient developed intolerable abdominal symptoms after 0-4 years on gluten challenge. She had no reticulin antibodies and the gliadin antibodies showed a slight positivity but the small bowel mucosa was normal. Despite subjective symptoms she continued the challenge and a second biopsy was performed because of the symptoms after 0-8 years on gluten challenge and the biopsy specimen showed slight partial villous atrophy. She still had no reticulin antibodies. She returned to a gluten free diet.
After two years on a gluten containing diet five patients were still negative for reticulin binding antibodies and had no symptoms. They all had a small bowel biopsy. One patient showed a flat mucosa and on retesting his serum the IgA class reticulin antibodies gave a titre of 1:10. Three girls and one boy did not relapse, and the mucosa was found to be normal. Thus four out of 38 patients (11%) showed a possible recovery from coeliac disease. All four had already undergone gluten challenge earlier in childhood at the ages of 2 to 5 and they had been on a gluten free diet before this challenge for a minimum of nine years. All nine patients with late initial diagnosis undergoing their first challenge relapsed.
IgA class gliadin antibodies were measured in all the sera. In 17 patients (59%) the gliadin antibodies rose to positive levels concomitant with reticulin antibodies, and in two cases eight to 11 months earlier. In four patients the gliadin antibody titre varied back and forth from a negative result to a positive one at the same time as the reticulin antibodies gave a negative result and in two patients IgA class gliadin antibodies remained negative during the challenge and at the time of mucosal relapse. In the four young adults fulfilling ESPGAN criteria with possible postpubertal mucosal recovery IgA class gliadin antibodies were throughout at negative levels in three and varied in one.
IgG class gliadin antibodies were at positive levels at the time of biopsy in 18 of the 23 cases with mucosal relapse. In four of these IgG class gliadin antibodies were positive before reticulin antibodies. The titres varied in two during the challenge, and four adolescents and young adults with mucosal relapse showed no IgG class gliadin antibodies. In the four cases with normal mucosa at two years of gluten challenge IgG class gliadin antibodies were not at positive levels throughout in two and were positive once in one and twice in another, but were not found to be positive later.
Discussion
To our surprise not all the patients showed permanence of the mucosal reaction to gluten. Four (11%) patients, three girls and one boy, still had a normal mucosa after two years on a normal gluten containing diet. They had all undergone a gluten challenge at a younger age and their mucosa had rela?sed, so the ESPGAN criteria had been fulfilled. 2 This finding can be explained in two ways. First, it is possible, as Schmitz et al have shown,5 that coeliac disease may disappear during adolescence in some patients, so that puberty could be a milestone in coeliac disease, changing to its currently familiar 'natural history'. Secondly, these patients could represent the extremity of normal biology, being only so called late relapsers who do not follow the 'two-year rule'. In fact, there is increasing evidence that the mucosa may deteriorate even after many years on a gluten containing diet," (I Polanco, J Larrauri. Abstract presented at International Coeliac Symposium, St Bartholomew's Hospital, London, 4-6 September, 1988) showing the diagnosis of transient gluten intolerance to be incorrect at least in these cases. Our four patients will be further followed up and it may of course turn out that the challenge is life long, meaning that the coeliac disease has healed. Without the present postpubertal gluten challenge study these patients would have continued unnecessarily on their gluten free diet.
Today it can be suggested that factors other than gluten ingestion are at least sometimes needed to induce mucosal damage in coeliac disease. An intriguing candidate trigger is adenovirus, as suggested by Kagnoff et al. '2 13 Such possibilities should be studied more extensively. The existence of external factors could offer explanations for the reported phenomenon of coeliac disease relapse over such a large range of time," 14 which has been confirmed in this study.
An interesting finding in the present study was the paucity of abdominal symptoms during gluten challenge. In most cases (70%) the mucosa relapsed before any symptoms had occurred. Recently Kumar et al also observed that teenagers with coeliac disease not following a strict gluten free diet, and with mucosal abnormality, were clinically asymptomatic. ' 
